Literature DB >> 32207184

Molecular Interrogation to Crack the Case of O-GlcNAc.

Arielis Estevez1, Dongsheng Zhu1, Connor Blankenship1, Jiaoyang Jiang1.   

Abstract

The O-linked β-N-acetylglucosamine (O-GlcNAc) modification, termed O-GlcNAcylation, is an essential and dynamic post-translational modification in cells. O-GlcNAc transferase (OGT) installs this modification on serine and threonine residues, whereas O-GlcNAcase (OGA) hydrolyzes it. O-GlcNAc modifications are found on thousands of intracellular proteins involved in diverse biological processes. Dysregulation of O-GlcNAcylation and O-GlcNAc cycling enzymes has been detected in many diseases, including cancer, diabetes, cardiovascular and neurodegenerative diseases. Here, recent advances in the development of molecular tools to investigate OGT and OGA functions and substrate recognition are discussed. New chemical approaches to study O-GlcNAc dynamics and its potential roles in the immune system are also highlighted. It is hoped that this minireview will encourage more research in these areas to advance the understanding of O-GlcNAc in biology and diseases.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  O-GlcNAc; chemical tools; glycosylation; inhibitors; substrate recognition

Mesh:

Substances:

Year:  2020        PMID: 32207184      PMCID: PMC7724648          DOI: 10.1002/chem.202000155

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  140 in total

1.  Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

Authors:  Thomas P Lynch; Christina M Ferrer; S RaElle Jackson; Kristina S Shahriari; Keith Vosseller; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Molecular recognition of carbohydrates with artificial receptors: mimicking the binding motifs found in the crystal structures of protein-carbohydrate complexes.

Authors:  Monika Mazik; Hüseyin Cavga; Peter G Jones
Journal:  J Am Chem Soc       Date:  2005-06-29       Impact factor: 15.419

3.  A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.

Authors:  Scott A Yuzwa; Matthew S Macauley; Julia E Heinonen; Xiaoyang Shan; Rebecca J Dennis; Yuan He; Garrett E Whitworth; Keith A Stubbs; Ernest J McEachern; Gideon J Davies; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2008-06-29       Impact factor: 15.040

4.  A beta-mannoside-selective pyrrolic tripodal receptor.

Authors:  Cristina Nativi; Martina Cacciarini; Oscar Francesconi; Gloriano Moneti; Stefano Roelens
Journal:  Org Lett       Date:  2007-10-10       Impact factor: 6.005

Review 5.  O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.

Authors:  Scott A Yuzwa; David J Vocadlo
Journal:  Chem Soc Rev       Date:  2014-04-24       Impact factor: 54.564

6.  Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies.

Authors:  Harold G Selnick; J Fred Hess; Cuyue Tang; Kun Liu; Joel B Schachter; Jeanine E Ballard; Jacob Marcus; Daniel J Klein; Xiaohai Wang; Michelle Pearson; Mary J Savage; Ramesh Kaul; Tong-Shuang Li; David J Vocadlo; Yuanxi Zhou; Yongbao Zhu; Changwei Mu; Yaode Wang; Zhongyong Wei; Chang Bai; Joseph L Duffy; Ernest J McEachern
Journal:  J Med Chem       Date:  2019-09-29       Impact factor: 7.446

7.  Artificial Cysteine S-Glycosylation Induced by Per-O-Acetylated Unnatural Monosaccharides during Metabolic Glycan Labeling.

Authors:  Wei Qin; Ke Qin; Xinqi Fan; Linghang Peng; Weiyao Hong; Yuntao Zhu; Pinou Lv; Yifei Du; Rongbing Huang; Mengting Han; Bo Cheng; Yuan Liu; Wen Zhou; Chu Wang; Xing Chen
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-05       Impact factor: 15.336

Review 8.  Stress-induced O-GlcNAcylation: an adaptive process of injured cells.

Authors:  Marissa R Martinez; Thiago Braido Dias; Peter S Natov; Natasha E Zachara
Journal:  Biochem Soc Trans       Date:  2017-02-08       Impact factor: 5.407

9.  Binding Studies on a Library of Induced-Fit Synthetic Carbohydrate Receptors with Mannoside Selectivity.

Authors:  Kalanidhi Palanichamy; M Fernando Bravo; Milan A Shlain; Frank Schiro; Yasir Naeem; Mateusz Marianski; Adam B Braunschweig
Journal:  Chemistry       Date:  2018-08-22       Impact factor: 5.236

10.  Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase.

Authors:  Chia-Wei Hu; Matthew Worth; Dacheng Fan; Baobin Li; Hao Li; Lei Lu; Xiaofang Zhong; Ziqing Lin; Liming Wei; Ying Ge; Lingjun Li; Jiaoyang Jiang
Journal:  Nat Chem Biol       Date:  2017-10-23       Impact factor: 15.040

View more
  5 in total

1.  Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe.

Authors:  Adam Kositzke; Dacheng Fan; Ao Wang; Hao Li; Matthew Worth; Jiaoyang Jiang
Journal:  Int J Biol Macromol       Date:  2020-12-18       Impact factor: 6.953

2.  O-GlcNAc Engineering on a Target Protein in Cells with Nanobody-OGT and Nanobody-splitOGA.

Authors:  Daniel H Ramirez; Yun Ge; Christina M Woo
Journal:  Curr Protoc       Date:  2021-05

3.  Shiga toxin (Stx) type 2-induced increase in O-linked N-acetyl glucosamine protein modification: a new therapeutic target?

Authors:  Rebecca A Bova; Angela Melton-Celsa
Journal:  EMBO Mol Med       Date:  2021-12-22       Impact factor: 12.137

4.  O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling.

Authors:  Liming Wu; Yaxian Cheng; Didi Geng; Zhiya Fan; Bingyi Lin; Qiang Zhu; Jingchao Li; Weijie Qin; Wen Yi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-03       Impact factor: 12.779

5.  The role of human antigen R (HuR) in modulating proliferation, senescence and radiosensitivity of skin cells.

Authors:  Daojiang Yu; Yahui Feng; Zhiqiang Jiang; Tao Yan; Kai Fang; Yuhong Shi; Jie Zhang; Shuyu Zhang
Journal:  Exp Ther Med       Date:  2022-07-12       Impact factor: 2.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.